Please login to the form below

Not currently logged in
Email:
Password:

Pharma approval

This page shows the latest Pharma approval news and features for those working in and with pharma, biotech and healthcare.

Roche scores EU approval twice for Tecentriq in lung cancer

Roche scores EU approval twice for Tecentriq in lung cancer

The approval in ES-CLC is the first cancer immunotherapy approved in Europe in this indication as an initial treatment. ... It is  already approved in the treatment of patients with NSCLC which is EGFR-mutant or ALK-positive, so this approval widens the

Latest news

More from news
Approximately 2 fully matching, plus 307 partially matching documents found.

Latest Intelligence

  • What pharma marketers can learn from Disney

    In pharma, ‘channel’ is often used broadly to refer to the routes for communicating with customers. ... No problem, you can still dunk in the dark.’. For those who think this is not a possibility in the pharma industry given the lengthy approval

  • From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality

    Therefore, it was exciting to hear at ISMPP EU 2019 that most pharma-sponsored clinical trial publications in the oncology space now include a patient acknowledgement. ... Importantly, pharma compliance teams have to find approval pathways that can

  • Visualising medicine Visualising medicine

    Pharma is among the most highly regulated marketing sectors that exist today, after all. ... This is particularly important with pharma, where mould-breaking solutions are integral to creating accessible messaging for life-changing products.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    set to gain approval in both regions in the first half of 2019. ... GW Pharma gained an historic approval for its drug Epidiolex from the FDA in June last year, becoming the first ever prescription medicine derived from cannabis.

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    And then there is the problem of public opinion. “We have a ridiculously low approval rating for an industry that saves so many lives,” remarked the president of one of the ... With a net approval rating of minus 23, pharma sits only marginally above

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • NEW FROM GOWER

    Arthur G. Cook's second edition of Forecasting for the Pharmaceutical Industry is now available. The book is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making

  • vector pharma

    vector pharma specialises in the provision of close strategic regulatory support to innovative small to medium-size development-phase pharma companies seeking product approval within the EU. ... vector pharma works very closely with clients on a limited

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics